Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | March 2016

An Interview With Yann Gouëffic, MD, PhD

The vascular surgeon weighs in on the current reimbursement climate in France, concerns about radiation exposure, and what is needed most in future lower limb trials.

evt | Article | August 2015

Global Perspectives on SFA Treatment: France

By Yann Gouë,ffic, MD, PhD

evt | Article | September 2020

Update on SFA Interventions

By Yann Gouëffic, MD, PhD, and Eric A. Secemsky, MD, MSc

evt | Article | September 2017

Perspectives: Does Care Drive Reimbursement or Vice Versa?

By Tony S. Das, MD, FACP, FACC; and Yann Gouëffic, MD, PhD

Advertisement

Sponsored by Biotronik

evt | Article | September 2018 Supplement

Assessing the Economic Impact of Peripheral Interventions

The difficulties in weighing cost-effectiveness in treatment algorithms remain.

By Yann Gouëffic, MD, PhD; and Valéry-Pierre Riche

Sponsored by Boston Scientific Corporation

evt | Article | October 2016 Europe Supplement

Global Perspectives on Drug-Eluting Technologies

With Prof. Thomas Zeller, MD; Antonio Micari, MD, PhD; Konstantinos Katsanos, MSc, MD, PhD, EBIR; and Yann Gouëffic, MD, PhD

evt | Article | September 2021

Panel Discussion: CFA Disease: Exploring Options in a Typically Surgical Indication

Moderator Peter A. Schneider, MD, asks Daniela Branzan, MD; Daniel Clair, MD; Tony Das, MD, FACC; and Yann Gouëffic, MD, PhD, about their approaches to CFA lesions, patient and clinical factors they consider, data that support an endovascular approach, preferred tools and rules of thumb, and how treatment of CFA disease looks in the future.

Sponsored by Boston Scientific Corporation

evt | Article | January 2019 Supplement

Discussing the IMPERIAL Data in Practice

Two vascular experts share their reactions to hearing the results of the first head-to-head peripheral DES trial.

With Yann Gouëffic, MD, PhD; and Andrew Holden, MBChB, FRANZCR, EBIR

evt | Article | January 2020

Image Fusion for Vascular Procedures

The impact and continuing development of image fusion for planning and guiding vascular repair.

By Stéphan Haulon, MD, PhD; Dominique Fabre, MD, PhD; Justine Mougin, MD; Philippe Charbonneau, MD; Antoine Girault, MD; Maxime Raux, MD; and Yann Gouëffic, MD, PhD

Sponsored by Penumbra, Inc.

evt | Article | July 2021

Mechanical Power Aspiration With the Indigo® System in Pulmonary Emboli, Venous Occlusions, and Acute Limb Ischemia

With John M. Moriarty, MD, FSIR, FSVM; Andrew Yates; Massimo Pieraccini, MD; Alessio Puliti, MD; Andrea Picchi, MD; Thomas Le Houérou, MD; Yann Gouëffic, MD, PhD; Reinhold Perkmann, MD; Giovanni Coppi, MD; and Carlo Patrizio Dionisi, MD

evt | News | December 16, 2025

Data From Medtronic’s French QoL Registry for In.Pact Admiral DCB Presented

December 16, 2025—Medtronic announced that results from the company-sponsored In.Pact Admiral drug-coated balloon (DCB) French Quality of Life (QoL) registry were presented by Professor Yann Gouëffic, MD, at the Paris Vascular Insights Course.

evt | News | December 12, 2016

TAILOR Postmarket Study Begins for Jotec's E-liac Stent Graft System

December 13, 2016—Jotec GmbH announced that the first patients have been enrolled in the TAILOR prospective, multicenter, postmarket study of the company's branched E-liac stent graft system for the endovascular treatment of iliac aneurysms.

Sponsored by iVascular

evt | Article | September 2020

Drug-Coated Balloon Update: Are All DCBs the Same?

A summary of presentations on the use of DCBs and treatment of complex lesions from the inaugural iVS.

With Fabrizio Fanelli, MD, EBIR; Prof. Ulf Teichgräber, MD; and Koen Deloose, MD

evt | News | October 6, 2021

Boston Scientific’s Eluvia Drug-Eluting Vascular Stent Compared to BMS at 1 Year in EMINENT Study

October 6, 2021—Boston Scientific announced the presentation of data for the Eluvia drug-eluting vascular stent system, which included 1-year results from the EMINENT trial that demonstrated superiority of the Eluvia stent compared to self-expanding bare metal stents (BMS) for the treatment of patients with peripheral artery disease and superficial femoral artery (SFA) or popliteal artery (PPA) lesions up to 210 mm in length.

evt | News | May 5, 2019

iD3 Medical Announces the Start of the BIOPACT-RCT Trial

May 6, 2019—iD3 Medical announced that it has received approval in Belgium to begin the physician-initiated, multicenter, randomized controlled BIOPACT-RCT trial.

evt | News | December 13, 2024

Sensome’s Clotild Smart Guidewire Evaluated for Identifying Fresh Clot in PAD

December 13, 2024—Sensome, a developer of microsensing technology for instant intra-operative tissue analysis, announced that results from two studies of its Clotild smart guidewire system demonstrated the device’s ability to identify “fresh” clot—thrombus rich in red blood cells (RBCs)—in peripheral artery disease (PAD) and differentiate it from other tissue encountered during PAD procedures.

evt | Article | March 2016

The Latest in Complex EVAR

By Jason T. Lee, MD; and Stéphan Haulon, MD, PhD

evt | Article | September 2019

Nine Months Later… An Interview With Konstantinos Katsanos, MD

Dr. Katsanos's thoughts regarding the vascular community's reaction to his group's meta-analysis, the potential influence of follow-up and adjudication variables, non-SFA applications, and what comes next.

With Konstantinos Katsanos, MSc, MD, PhD, EBIR

evt | Article | September 2021

Femoropopliteal Disease: Challenges and Progress

By Marianne Brodmann, MD, and Ehrin J. Armstrong, MD, MSc, MAS, FACC, FSCAI, FSVM

Sponsored by Spectranetics

evt | Article | Europe May 2015 Supplement

The ILLUMENATE Clinical Program

Demonstrating the efficacy of the Stellarex™ drug-coated balloon.

By Henrik Schrö,der, MD

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button